Global /South Korea /Healthcare /Medical Devices /460470
chevron_leftBack
IVIM Technology, Inc. logo

IVIM Technology, Inc.

460470
KRX: 460470 Delayed
3,880KRW 18%
2.54 USD
As of 13 June 2026, IVIM Technology, Inc. has a market cap of $32.81M USD, ranking #33627 globally and #2049 in South Korea. It ranks #3038 in the Healthcare sector, and #640 in the Medical Devices industry.
Global Rank
33627
Country Rank
2049
Sector Rank
3038
Industry Rank
640
Key Stats
Market Cap
$32.81MUSD
49.89B KRW
Enterprise Value
$23.54MUSD
35.93B KRW
Revenue (TTM)
$2.88MUSD
4.38B KRW
EBITDA (TTM)
-$1.51MUSD
-2.3B KRW
Net Income (TTM)
-$2.5MUSD
-3.8B KRW
EBITDA Margin
-53%
Profit Margin
-87%
PS Ratio
11.4
PB Ratio
1.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Pilhan Kim open_in_new
Founded
2017
Website
ivimtech.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
18% -5.2% -9.6% 8.6% -1.3% -13%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
460470
아이빔테크놀로지 주식회사
ISIN: KR7460470008
Shares Out.:
15.119M1 Shares Float: 8.359M2
TV:
SA:
YF:
GF:
BA:
MS:
3,880 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About IVIM Technology, Inc.

IVIM Technology, Inc. develops intravital microscopy (IVM) platform. Its products include IVM-C3, a system for simultaneously observing various multi-cellular behaviors in small live animal models; IVM-M3, a system for users who need to conduct deeper-tissue imaging using less-scattering NIR wavelength; IVM-CMS3 for intravital functional imaging; IVM-CM3 that provides three-dimensional imaging of living cells near the skin or deep into the tumor in small animals; IVM-MS3 for in vivo imaging; and IVM-customized products. The company also provides preclinical contract research organization services. Its products are used in live cell intravital imaging, repetitive intravital imaging, in vivo drug efficacy monitoring, in vivo drug delivery monitoring, and ex vivo imaging applications. The company was founded in 2017 and is based in Daejeon, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)
Name
Market Cap diff.
PE
214150
$2.47B
3.75T KRW
7K%
28.7
458870
$1.23B
1.86T KRW
4K%
114.8
491000
$1.19B
1.81T KRW
4K%
-
290650
$1.14B
1.74T KRW
3K%
-
096530
$759.58M
1.16T KRW
2K%
23.9
214430
$532.37M
809.64B KRW
2K%
83.3
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
528K%
25.8
$160.73B
490K%
56.7
$159.07B
485K%
25.6
DHR
$126.55B
386K%
34.7
SYK
$120.69B
368K%
38.3
MDT
$101.9B
311K%
22.2
chevron_leftBack